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To examine the expression of the cellular homolog of the Abelson murine
leukemia virus transforming gene (the v-abl sequence), a DNA probe representing
the v-abl sequence was prepared. The probe detected two cytoplasmic polyade-
nylic acid-containing c-abl RNAs of about 6.5 and 5.5 kilobases in a variety of
rodent cells, and slightly larger RNAs were detected in human cells. These two
RNA species were found in all normal tissues or cell lines examined, but at
differing concentrations: liver cells had the least, fibroblastic cell lines had the
most. By using a probe able to detect the cellular but not the viral gene, the two
RNAs were shown to be present in Abelson murine leukemia virus-transformed
cells at levels found either in their untransformed counterparts or in similar cell
types transformed by other means. The target cells of the virus have a somewhat
elevated level of the two RNAs although expression of the c-abl gene is not
restricted to these cells. The v-abl sequence lacks 0.35 and 0.85 kilobases of the c-
abl RNA on the 5' and 3' ends, respectively. Thus, the Abelson murine leukemia
virus transforming gene is an internal fragment of the transcript of a normal
cellular gene.
Abelson murine leukemia virus (A-MuLV)
has a hybrid genome composed of Moloney
MuLV (M-MuLV) terminal sequences sur-
rounding an internal sequence (v-ab) derived
from a region of the normal mouse DNA (c-abl)
(8, 17). The virus is similar in structure to many
other transforming retroviruses (18). The v-abl
sequence is linked in phase to the gag gene ofM-
MuLV, with terminal viral sequences providing
the necessary signals for a high-level expression
of the gaglv-abl fusion protein. The fusion pro-
tein is the only protein product of the A-MuLV
genome and is responsible for the transforming
activity of the virus (21).
The c-abl sequence homologous to the 4.3-
kilobase (kb) v-abl is distributed along 30 kb of
mouse DNA as what appears to be a series of
short exons separated by long introns (8; J. Y. J.
Wang, S. P. Goff, F. Ledley, Y. Groner, and D.
Baltimore, manuscript in preparation). That the
c-abl sequence represents exons is supported by
the findings of polyadenylic acid [poly(A)]-con-
taining RNA homologous to v-abl in various
mammalian cells. Studies of the expression of c-
abl RNA during murine embryogenesis (11) or in
human tumors (6, 13) have been reported. We
prepared a full-length v-abl probe and used it to
examine c-abl RNA in mouse tissues and cell
lines with an emphasis on lymphoid cells. The
expression of c-abl RNA in A-MuLV-trans-
formed cells was also examined. In addition, we
have analyzed the structural relationship be-
tween the v-abl sequence and c-abl RNA.
MATERIALS AND METHODS
Construction of pABlsub9 probe. The plasmid pAB1
(Fig. 1) was digested with Kpnl which cut the plasmid
at a unique site in the long terminal repeated portion of
the viral genome. The linearized molecule was treated
with a predetermined amount of Bal31 nuclease and
was then blunt-end ligated. Escherichia coli HB101
was transformed with the total ligated DNA, and the
ampicillin-resistant colonies were hybridized with an
M-MuLV DNA probe. Plasmid DNA was prepared
from colonies that did not hybridize to the M-MuLV
probe. From these plasmids, pAB1sub9 was chosen
because of its restriction enzyme digestion pattern and
because it hybridized well to A-MuLV DNA but
poorly to M-MuLV DNA. The presence of a small
amount of homology to M-MuLV ensured that this
plasmid retained the complete 5' end of the v-abl
sequence. Its content of M-MuLV sequence was so
short that it reacted with total cellular RNA and
genomic DNA as a v-abl-specific probe.
Preparation of cellular RNA. Total cellular RNA was
prepared from an 8 M guanidine-hydrochloride lysate
of cells by repeated precipitation with 33% ethanol, as
described by Deeley et al. (5). Cytoplasmic RNA was
isolated by lysing the cells in buffer containing 10 mM
NaCI, 10 mM Tris-hydrochloride (pH 7.4), 10 mM
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FIG. 1. v-abl probes used for the detection of ho-
mologous cellular RNA. Plasmid pAB1 is a permuted
clone of the A-MuLV genome (8). Plasmid pAB1sub9
was derived from pAB1 as described in the text. The 5'
probe, middle probe, and 3' probe were fragments
released by restriction enzyme digestion of pAB1sub9
and were prepared by preparative gel electrophoresis.
The clear area represents sequences derived from M-
MuLV, the cross-hatched area represents the A-
MuLV specific sequences, and the thin line represents
pBR322 sequences. Restriction enzymes: H, HindIll;
B, BamHI; K, KpnI; Hc, HincII; BgI, BgIl; BgII,
BglII.
MgCl2, 0.5% Nonidet P-40, 0.5% deoxycholate, 500 p.g
of heparin per ml, and 500 p.g of spermidine per ml.
After 10 strokes with a Dounce homogenizer, nuclei
were removed by centrifugation, and RNA was precip-
itated with 66% ethanol. The pellet was then dissolved
in the 8 M guanidine-hydrochloride buffer, and repeat-
ed precipitation with 33% ethanol was carried out.
After the final 33% ethanol precipitation step, the
RNA pellet was dissolved in 20 mM EDTA (pH 7.4)
and extracted three times with chloroform-isobutanol
(4:1). The extracted RNA was dissolved in 10 mM
Tris-hydrochloride (pH 7.4)-0.5% sodium dodecyl sul-
fate-1 mM EDTA plus 400 mM NaCl at a concentra-
tion so that the absorbance at 260 nm of the solution
was 10. Poly(A)-containing RNA was then selected by
chromatography on oligodeoxythymidylic acid-cellu-
lose. Those RNAs that were bound to oligodeoxythy-
midylic acid-cellulose at 400 mM NaCl and eluted with
the same buffer minus NaCl were used in the hybrid-
ization experiments.
RNA hybridizations. Poly(A)-containing RNA was
denatured in 10 mM methylmercury and applied to a
1% agarose gel in 5 mM methylmercury-containing E
buffer (50 mM boric acid, 5 mM Na2B407 * 10H20, 10
mM sodium sulfate, 1 mM EDTA [pH 8.2]). After
electrophoresis (100 V, 6 h), the RNA was transferred
onto diazobenzyloxymethyl-paper (DBM-paper) as
described (2).
The DBM-paper was hybridized with 32P-labeled
probes (2 x 108 to 6 x 108 cpm/,lg) by using dextran
sulfate according to the method of Wahl et al. (19). To
reuse the blot, labeled probe was washed off in 99%o
formamide-0.1% sodium dodecyl sulfate at 65°C.
Quantitative dot-blot hybridization. A given quantity
of poly(A)-containing RNA in 1 p.l was mixed with 1
of 100 mM NaOH at room temperature for 2 min and
then neutralized with 1 p.l of 100 mM HCI. The sample
was diluted to 10 .l1 with 0.2 M sodium acetate (pH
4.5) and spotted in 2-p.l aliquots onto freshly activated
DBM-paper. Hybridization with 32P-labeled probes
was as described above. As a standard for compari-
son, poly(A)-containing RNA from ANN-1 cells (an A-
MuLV-transformed fibroblastic line) or 2M3 cells (an
A-MuLV-transformed pre-B cell line) was applied to
the DBM-paper in 10 ,ul containing 0.1, 0.05, 0.02,
0.01, and 0.005 ,ug. As a negative control, 1 ,ug of
poliovirus RNA was used. The other RNA samples
were spotted on the same sheet of paper at given
amounts. The intensity of hybridization was compared
with the standards, and the level of the c-abl RNA as a
percentage of the A-MuLV viral RNA was deter-
mined.
Primer extension. Restriction fragments of the v-abl
region were prepared and labeled at their 5'-ends with
[y-32P]ATP and polynucleotide kinase. The labeled
DNA fragment plus 20 p.g of poly(A)-containing RNA
in 10 p.l of water was boiled for 2 min and chilled
immediately on dry ice. Hybridization was carried out
in 80% (vol/vol) formamide (deionized and recrystal-
lized)-0.4 M NaCl-0.01 M PIPES [piperazine-N,N'-
bis(2-ethanesulfonic acid)-hydrochloride] (pH 6.4)-2
mM EDTA at 42°C for 22 h. The hybridization mixture
was diluted with 200 p.1 of water and ethanol precipitat-
ed to remove formamide. The precipitate was dis-
solved in 100 p.l of 50 mM Tris-hydrochloride (pH 8.3),
50 mM KCl, 10 mM dithiothreitol, 10 mM MgCl2, 40
p.g of actinomycin D per ml, 600 p.M each of dATP,
dGTP, dCTP, and dTTP, and 6 U of reverse transcrip-
tase. After elongation of the primer for 1 h at 37°C,
NaOH was added to 0.1 M and the RNA was hydro-
lyzed at 68°C for 10 min. The extended DNA was
precipitated in ethanol, extracted with phenol, dis-
solved in 1.5 M glyoxal, and analyzed by electrophore-
sis through a 1.6% agarose gel.
RESULTS
c-abl RNA in mammalian cells. To examine
cells for c-abl RNA, total poly(A)-containing
RNA was prepared, size-fractionated by electro-
phoresis, transferred to derivatized paper, and
hybridized to one of the variety of v-abl probes
described in Fig. 1. When a probe for the whole
v-abl region was used (pABlsub9), two RNA
species were detected in several rodent and
human cell lines (Fig. 2). The RNAs were about
6.5 and 5.5 kb in rodent cells and 7.0 and 6.0 kb
in human (HeLa) cells. Both RNAs were present
in L-cell cytoplasmic RNA preparation (Fig. 2,
lane B), showing that the larger is not a nuclear
precursor of the smaller. All of the probes
described in Fig. 1 hybridized to both RNAs,
and the relative intensity of the two bands was
constant (data not shown). These results demon-
strate that the two RNAs are closely related, and
they suggest that v-abl is derived from a single
gene that gives rise to two different sizes of
mRNA.
Distribution of c-abl RNA in various mouse
cells. Twelve different types of cells have been
examined for the expression of c-abl RNA. They
include normal tissues and mouse cell lines. In
all cases examined, c-abl RNA of 6.5 and 5.5 kb
could be detected in approximately constant
ratios, although the absolute amount of total c-
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FIG. 2. c-abl RNA in mammalian cells. Poly(A)-
containing RNA was prepared and analyzed by hy-
bridization to 32P-labeled pAB1sub9 as described in
the text. Lanes: (A) 10 ,ug of total poly(A)-containing
RNA from rat hepatoma Fao cell line; (B) 10 p.g of
cytoplasmic poly(A)-containing RNA from mouse L
cells; (C) 10 Fg of total poly(A)-containing RNA from
mouse L cells; (D) 20 Fig of total poly(A)-containing
RNA from human HeLa cells.
abl RNA varied. The c-abl RNA content was
quantitated by dot-blot hybridization by using
varying amounts of RNA from A-MuLV-trans-
formed cells as a standard for comparison (Table
1). The highest expression of c-abl RNA was
found in established untransformed fibroblastic
cell lines; its level there was almost 1/10 that of
the v-abl RNA in transformed fibroblasts. A
primary fibroblast culture from BALB/c mouse
embryos was also found to contain this high
level of c-abl RNA. The cell density of the
cultures had no apparent effect on the level of c-
abl RNA. Among lymphoid cells, normal thy-
mocytes and a pre-B lymphoma line (70Z/3)
were the highest producers of c-abl RNA, and a
radiation-induced thymoma cell line, L691, had
half the amount of c-abl RNA of normal thymo-
cytes. Normal splenocytes from 5-week-old mice
had sixfold less c-abl RNA than thymocytes from
the same animals. In neonatal spleen, however,
the level of c-abl RNA was comparable to that of
thymocytes (11). It is not known how the c-abl
RNA is distributed among the different cells mak-
ing up thymocyte and splenocyte populations.
Normal liver had the least amount of c-abl RNA,
although a rat hepatoma cell line contained about
fourfold more (Table 1).
Retroviral RNA is usually present as 1% of
the total polyadenylated RNA (7). Because the
level of c-abl RNA in fibroblasts, thymocytes,
and a pre-B lymphoma was about 4 to 7% that of
the viral RNA in an A-MuLV transformant
(Table 1), the level of c-abl RNA in these cells is
approximately 0.05% of the total poly(A)-con-
taining RNA. The level of c-abl expression as
a percentage of the total poly(A)-containing RNA
in 13 samples is summarized in Table 1.
Expression of c-abl RNA in A-MuLV-trans-
formed cells. A-MuLV transforms fibroblasts
and pre-B lymphocytes in vitro (15, 16). Because
both fibroblasts and a pre-B lymphoma line had
relatively high levels of c-abl RNA, we exam-
ined whether c-abl RNA could be detected in A-
MuLV-transformed fibroblasts and pre-B cells.
A-MuLV RNA is of similar size as, and it is at
least 10-fold more abundant than, the endoge-
nous RNA, so that the v-abl probes used in
earlier experiments could not be used to detect
c-abl RNA in A-MuLV-transformed cells. A
solution to this problem became available when
the genome of another A-MuLV variant, A-
MuLV(P160), was molecularly cloned (10). The
A-MuLV(P160) genome contains 800 base pairs
(bp) more sequence than the A-MuLV(P120)
genome, which was used to prepare the
TABLE 1. Levels of c-abl RNA in mouse cells
c-abl c-abl as
Cell line Cell type as % % totalof poly(A)-
v-ablP RNA
NIH 3T3 Fibroblasts 7.0 0.07
BALB/3T3 Fibroblasts 7.0 0.07
L cells Fibroblasts 4.0 0.04
Normal thymocytes 5.0 0.05
(5-week-old mice)
L691 Radiation-induced 2.0 0.02
thymoma
70Z/3 Chemically induced 4.0 0.04
pre-B lymphoma
MOPC-11 Myeloma 2.0 0.02
MOPC-104E Myeloma 1.0 0.01
WEHI231 Chemically induced 1.4 0.014
B-cell lymphoma
745PC4 Friend virus-induced 2.0 0.02
erythroblastoid
Normal splenocytes 0.8 0.008
(5-week-old mice)
Liver 0.4 0.004
Fao Hepatoma (rat) 1.5 0.015
a Comparison of hybridization intensity between
RNA samples containing c-abl RNA and those con-
taining v-abl RNA on a dot-blot is described in the
text. For example, 1.5 ,ug of poly(A)-containing RNA
from NIH 3T3 fibroblasts gave the same intensity as
0.1 j±g of poly(A)-containing RNA from ANN-1 or
2M3 cells. Thus, the c-abl RNA is 1/15 of the v-abl
RNA, about 7%.
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FIG. 3. DNA probe used for the detection of c-abl
RNA in A-MuiLV-transformed cells. The genome of
A-MuLV(P160) is larger than that of A-MuLV(P120)
by 800 bp located within the PstI restriction fragment
indicated in the Figure. Within the 800-bp sequence is
a single Sacl site. The indicated restriction fragment
PS of 550 bp was chosen because it did not hybridize
to A-MuLV(P120) DNA but did hybridize to c-abl
RNA.
autoradiogram (Fig. 5, bottom, lanes 1). The
length of 2.1 kb is exactly the predicted distance
between the BglII site and the 5' end of A-
MuLV RNA.
To examine the c-abl RNA, two primers were
hybridized to, and extended on, poly(A)-con-
taining RNA of mouse L cells: one was labeled
at a SmaI site and was 550 bp long, and the other
was labeled at a SacI site and was 90 bp long
(Fig. 5). Because c-abl RNA was only 1/10 as
abundant as A-MuLV RNA, the bands of the
extension products were of low intensity and
were more clearly evident after the long expo-
sure shown in Fig. SB. The 550-bp primer yield-
ed a 900-bp extension product (Fig. 5, lane 2),
and the 90-bp primer gave a 1,425-bp product
pABlsub9 probe. [A-MuLV(P120) is actually a
deletion mutant of A-MuLV(P160).J As shown
in Fig. 3, this 800-bp extra segment is located in
a PstI fragment in the v-abl region. A PstI to
Sacl fragment (PS) derived from this region was
found to be specific to the A-MuLV(P160)
genome in that it did not hybridize to A-
MuLV(P120) DNA. Therefore, fragment PS
could be used to detect c-abl RNA in cells
transformed by the A-MuLV(P120) variant.
When the pABlsub9 and PS probes were hy-
bridized to RNA from NIH 3T3 or 70Z/3 cells,
both probes detected the same c-abl RNAs (Fig.
4, lanes 1 and 2). When RNA from A-
MuLV(P120)-transformed lymphoid cells was
hybridized with these probes, pABlsub9 gave
rise to the 5.5-kb viral RNA band (Fig. 4A, lanes
3, 4 and 6), but fragment PS detected the two c-
abl RNAs (Fig. 4B, lanes 3, 4, and 6). An RNA
sample from line 22D6, an A-MuLV(P160)-
transformed line, was also included in the ex-
periment to show that both probes hybridized to
the 6.3-kb viral RNA of A-MuLV(P160) (Fig. 4,
lanes 5). In fibroblasts transformed by A-
MuLV(P120), the two c-abl RNAs were also
detected. Thus, expression of the A-MuLV
genome does not repress the synthesis of c-abl
RNA.
Relationship between c-abl RNA and v-abl se-
quence. Because c-abl RNA is larger than the v-
abl sequence, we examined whether the ends of
the c-abl sequence were deleted during the for-
mation of the A-MuLV genome by primer exten-
sion experiments. Three different restriction
fragments from the 5' portion of the v-abl se-
quence were used as primers for reverse tran-
scriptase (Fig. 5). As a positive control, the
primer labeled at the BgII site was hybridized to
poly(A)-containing RNA from the A-MuLV-
transformed cell line, ANN-1. The longest re-
verse-transcription product was 2.1 kb, as evi-
denced by two different exposures of the
.H
.- N..
.X4...m
probe pABI sub 9
3 4 v
probe: fragment PS
e 7 ; .-,
FIG. 4. A-MuLV-transformed cells contain c-abl
RNA. Ten micrograms of total poly(A)-containing
RNA from the following cell lines was analyzed by
hybridization to 32P-labeled probes: (1) NIH 3T3, (2)
70Z/3, (3) 2M3, (4) 1-8, (5) 22D6, (6) 204. Cell
lines 2M3, 1-8, and 204 were transformed by A-
MuLV(P120), whereas cell line 22D6 was derived by
transformation with A-MuLV(P160). The DBM-paper
was first hybridized to 32P-labeled pAB1sub9 (A).
After exposure of the paper to X-ray film, the labeled
probe was washed off and a second hybridization with
32P-labeled fragment PS was performed (B). In (A),
lanes 1 and 2 are from a longer exposure (2 days) and
lanes 3 to 6 are from a shorter exposure (16 h) of the
same paper.
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FIG. 5. Primer extension of v-abl sequences on A-MuLV and c-abl RNA. The length and positions of the
three v-abl restriction fragments are as indicated (top). They were labeled at the 5' end with 32P, hybridized to
RNA, and extended with reverse transcriptase as described in the text. The molecular weight markers (MW) are
the in vitro run-off transcripts of adenovirus promoters (1,780, 1,270, and 974 bp) provided by Andrew Fire
(M.I.T). Two different exposures of a gel are presented: exposure (A) was for 24 h, exposure (B) was for 4 days
(bottom). (Lane 1) The SmaI-BgIII fragment hybridized to 10 gig of poly(A)-containing RNA from A-MuLV-
transformed fibroblasts, ANN-1, and extended with reverse transcriptase. (Lane 2) The HincII-SmaI fragment
hybridized to 20 ,ug of poly(A)-containing RNA from mouse L cells and extended. (Lane 3) The SmaI-Sacl
fragment hybridized to 20 gg of poly(A)-containing RNA from mouse L cells and extended.
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(Fig. 5, lane 3). In a separate experiment, the
120-bp primer labeled at BglII gave a 1,050-bp
extension product (data not shown).
The distance between the end of the reverse
transcriptase-generated product and the HincIl
site in v-abl can be calculated because the
sequence of the 5' region of v-abl has been
determined (R. Lee, J. Y. J. Wang, and D.
Baltmore, manuscript in preparation). The v-abl
sequence of A-MuLV begins 11 bp upstream
from the HincII site, and the HincII-BglII and
the HincII-SacI distances are 680 and 1,080 bp,
respectively. By subtracting the distance be-
tween the labeled end and the HincII site from
the final size of the extended product, we ob-
tained the distance between the 5' end of the
reverse transcriptase product and the 5' end of
v-abl. As shown in Fig. 5 (top), the three inde-
pendent primer extensions gave the consistent
result that the 5' end of the reverse transcriptase
product was about 355 bp upstream from the
HinclI site. Because the reverse transcriptase
products are well-defined bands, and because
the enzyme usually copies to the 5' end of RNA
molecules (14), we assume that the distances
measured correspond to the distance from the
HincII site to the 5' end of the c-abl RNA. The
positive control shown in Fig. 5 (lanes 1) also
substantiates this assumption.
Although both the 5.5-kb and the 6.5-kb c-abl
RNA were present in the hybridization reac-
tions, only one extended product was observed
with all three fragments. Thus, the 1-kb differ-
ence between the two RNAs does not appear to
be at the 5' end. It is most likely that these two
RNAs differ at the 3' end and they arise from use
of alternative polyadenylation sites.
The 4.3-kb v-abl sequence plus the 0.35-kb c-
abl-specific sequence at the 5' end can account
for 85% of the 5.5-kb c-abl RNA, but approxi-
mately 0.85 kb remains to be localized. Recent-
ly, we have obtained a 1.4-kb cDNA clone of the
c-abl RNA from a cDNA library from mouse L
cells constructed by H. Okayama and P. Berg
(12). Analysis of this clone by restriction en-
zyme digestion and sequencing has demonstrat-
ed that the c-abl RNA is 0.85 kb longer than v-
abl at the 3' end (F. Ledley, J. Y. J. Wang, and
D. Baltimore, unpublished data). This result
places the deleted 0.85 kb of c-abl sequence on
the 3' end of the RNA and verifies that reverse
transcriptase copied to the end of the c-abl RNA
in the primer extension experiment.
DISCUSSION
Levels of c-abl RNA. Compared to other c-onc
RNAs, the levels of c-abl transcripts are, in
general, higher. Even at its lowest, i.e., in the
liver, the level of c-abl RNA is an order of
magnitude higher than that of c-myb, c-myc, or
c-src RNA in the same tissue (9, 11). The
observation that all mouse cells and tissues
examined contain relatively high levels of c-abl
RNA shows that the c-abl product is not a
specialized protein of certain differentiated cells.
The approximately 10-fold difference of c-abl
RNA concentration between liver and thymus,
however, does indicate that the c-abl expression
is variable and possibly regulated. The c-abl
RNA is abundant in cultured cells of all types
with the exception of the one myeloma cell line
examined (MOPC-104E), but we find no obvious
correlation of the level of c-abl RNA with malig-
nancy. The only notable regularity is in the
lymphoid cell lineage, where the expression of
the c-abl gene is higher in immature cells than in
mature cells.
Previous studies have identified a cellular
protein called NCP150 that shares antigenicity
with the v-abl-encoded polypeptide sequence
(20). That protein was much more abundant in
thymus than in other tissues, a result consistent
with the relatively high level of c-abl RNA in
thymocytes and in a thymoma. Formerly, how-
ever, NCP150 was not found in fibroblastic
cells. The demonstration that they contain about
the same level of c-abl RNA as do thymocytes
prompted a reinvestigation, and it has been
possible to identify 32P-labeled NCP150 in fibro-
blasts (O. Witte, personal communication).
Types of c-abl RNA. In all tissues and cells
containing the c-abl RNA there are two species
present differing in size by about 1 kb. Only
these two species of RNA have been observed;
smaller c-abl-related RNAs found by others in
human tumor cells (6) have not been seen in this
laboratory or in another laboratory (13). The two
c-abl RNAs appear to come from the same gene
for two reasons. First, DNA probes specific for
the 3' or 5' end of the v-abl region react to the
same extent with both RNA species, indicating
that they share homology over much of their
length. Second, we have only been able to detect
one region of mouse DNA with substantial ho-
mology to a v-abl probe (8; Wang et al., in
preparation). The primer extension results indi-
cate that the two c-abl RNAs are most likely to
differ at their 3' ends.
c-abl expression in A-MuLV transformants. By
using as a probe a region of the v-abl DNA
absent from the A-MuLV(P120) genome, we
could show that A-MuLV lymphoid transform-
ants contain about as much c-abl RNA as a cell
line of similar phenotype transformed by other
means (70Z13 cells). A-MuLV fibroblastic trans-
formants also have about the same level of c-abl
RNA as their untransformed counterparts.
Thus, expression of the A-MuLV(P120) genome
neither enhances nor represses the expression of
the c-abl gene.
MOL. CELL. BIOL.
CELLULAR HOMOLOG OF A-MuLV TRANSFORMING GENE
Assuming that the level of c-abl RNA in the
A-MuLV transformant is characteristic of its
level in the target cell (pre-B lymphocytes), the
A-MuLV target cell would appear to have a
relatively high expression of the c-abl gene. The
A-MuLV transformant is probably a good model
of its normal counterpart because of their similar
surface antigens (3) and their immunoglobulin
gene configuration (1). Other cells that have
relatively high levels of c-abl RNA (thymocytes
and fibroblasts) are also targets for A-MuLV
transformation under certain circumstances (4,
16). It is possible that cells with higher expres-
sion of the c-abl gene are more susceptible to A-
MuLV transformation. This observed correla-
tion between c-abl expression and A-MuLV
transformation, however, does not necessarily
explain the target specificity.
A-MuLV contains a fragment of the c-abl RNA.
Our results show that the v-abl region of the A-
MuLV(P160) genome is an internal fragment of
the c-abl RNA and that about 0.35 kb on the 5'
end and 0.85 kb (or 1.85 kb) on the 3' end of the
cellular RNA were eliminated during the forma-
tion of the A-MuLV hybrid genome. Some of the
c-abl RNA coding sequence on the 5' end must
be deleted because there is no ATG codon at the
extreme 5' end of v-abl. How much, if any, of
the 3' coding sequence is present in the 0.85-kb
deletion is unknown; the size of the c-abl-en-
coded protein (Mr = 150,000) compared to that
encoded by v-abl (Mr = 130,000) suggests that
some c-abl coding sequence is absent from A-
MuLV. It is possible that the loss of c-abl coding
sequence contributes to the oncogenicity of A-
MuLV.
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